AT&T Completes $6.5B Bond Offering, Unveils New Youth Phone
Markets Daniel Marsh

AT&T Completes $6.5B Bond Offering, Unveils New Youth Phone

AT&T shares declined 0.7% to $27.13 Friday following a $6.5 billion multi-tranche bond sale and the launch of its amiGO Jr. Phone for children.

T VZ TMUS XLK
Verizon's Rally Halts Amid Leadership Shift, Focus Turns to Economic Data
Markets Daniel Marsh

Verizon's Rally Halts Amid Leadership Shift, Focus Turns to Economic Data

Verizon shares dropped 1.7% on Friday, ending a seven-day advance. The decline followed a management change in its consumer division, with investors now eyeing upcoming U.S. jobs and inflation reports.

VZ T TMUS
Texas Instruments Lags Chip Rally as Investors Eye Acquisition and Spending Plans
Technology Sarah Chen

Texas Instruments Lags Chip Rally as Investors Eye Acquisition and Spending Plans

Texas Instruments shares declined 1.13% on Friday, underperforming a broader semiconductor surge. The company's annual report outlined 2025 revenue of $17.68 billion and reduced 2026 capital expenditure plans.

TXN NVDA AMD AVGO XLK
Thermo Fisher Shares Stabilize After 4% Drop as Plant Closure and Macro Data Loom
Markets Daniel Marsh

Thermo Fisher Shares Stabilize After 4% Drop as Plant Closure and Macro Data Loom

Thermo Fisher Scientific's stock held near $543 Friday following a sharp decline. The company plans to close a Massachusetts facility by 2026, affecting 80 jobs, while investors await key U.S. economic reports.

TMO DHR XLV
Disney Shares Rally on Market Surge, Investors Eye Super Bowl and CEO Transition
Markets Daniel Marsh

Disney Shares Rally on Market Surge, Investors Eye Super Bowl and CEO Transition

Disney stock climbed 3.6% to $108.70 Friday, lifted by a broad market rally. Focus shifts to Super Bowl streaming economics and the upcoming CEO transition.

DIS NFLX AMZN FOX CMCSA
Novo Nordisk Shares Rebound as Hims Halts Wegovy Copycat After FDA Pressure
Regulation James Calloway

Novo Nordisk Shares Rebound as Hims Halts Wegovy Copycat After FDA Pressure

Novo Nordisk's Class B shares surged 5.3% after Hims & Hers discontinued its compounded Wegovy pill following U.S. regulatory warnings. The stock had dropped nearly 8% when the copycat launched.

NVO
Amgen Reaches 52-Week Peak on Friday; Investors Eye Inflation Data and Drug Pricing
Markets Daniel Marsh

Amgen Reaches 52-Week Peak on Friday; Investors Eye Inflation Data and Drug Pricing

Amgen shares surged 4.5% to close at $384.32 on Friday, achieving a new 52-week high. Market participants are monitoring upcoming U.S. inflation figures and developments in drug pricing.

AMGN CVS LLY XLV
Linde Shares Slide on 2026 Guidance, JPMorgan Downgrade
Earnings James Calloway

Linde Shares Slide on 2026 Guidance, JPMorgan Downgrade

Linde stock fell 2.5% after issuing 2026 EPS guidance below consensus. JPMorgan downgraded the stock, while Morgan Stanley and UBS raised price targets.

LIN
Inditex Initiates €180M Share Buyback, Stock Nears €58 Level
Markets Daniel Marsh

Inditex Initiates €180M Share Buyback, Stock Nears €58 Level

Inditex shares gained 0.78% to €57.14 as the company launched a €180 million share repurchase program. Investors now await full-year results scheduled for March 11.

BBVA
GE Vernova Surges 5.6% on Wind Orders and Acquisition Close
Markets Daniel Marsh

GE Vernova Surges 5.6% on Wind Orders and Acquisition Close

GE Vernova shares climbed nearly 6% Friday following new U.S. wind repower orders and completion of a major transformer acquisition. Investors await key U.S. economic data next week.

GEV
Citigroup Surges 6% on Regulatory Progress, Eyes Key Data and Conferences
Regulation James Calloway

Citigroup Surges 6% on Regulatory Progress, Eyes Key Data and Conferences

Citigroup shares rallied 6% Friday amid optimism over resolving long-standing consent orders. The bank also announced a $2.3 billion preferred stock redemption and employee account matching.

C BAC WFC JPM GS XLK XLF
T-Mobile Shares Dip Ahead of Key Financial Outlook and Earnings Report
Earnings James Calloway

T-Mobile Shares Dip Ahead of Key Financial Outlook and Earnings Report

T-Mobile US stock declined 2.2% to $197.39 Friday, underperforming the broader market as investors await the company's updated 2026-27 targets and Q4 earnings on Feb. 11.

TMUS VZ